Ekso Bionics (EKSO) Plans Public Offering of Common Stock and Warrants

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it is commencing an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. All the shares and warrants to be sold in the offering will be offered by Ekso. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Cantor Fitzgerald & Co. is acting as lead book-running manager and SunTrust Robinson Humphrey, Inc. is acting as joint book-running manager for the proposed offering.

The Company intends to use the net proceeds, if any, from the sale of the shares of common stock and warrants in the offering (and from the exercise, if any, of the warrants issued in the offering) for general corporate purposes, which may include acquisitions, research and development activities, capital expenditures, selling, general and administrative costs, facilities expansion, and to meet working capital needs.

You May Also Be Interested In

• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• enVVeno Medical (NVNO) files $100M mixed shelf
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings